Evidence map›Paper›PMID 37735500›Full record

ArticleCellular & molecular immunology2024

Cancer-associated fibroblasts express CD1d and activate invariant natural killer T cells under cellular stress.

Shengduo Pei, Jonas Sjölund, Yueyun Pan, Kristian Pietras, Mikael C I Karlsson

Erratum issuedOpen access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular & molecular immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shengduo PeiDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Jonas SjölundDivision of Translational Cancer Research, Department of Laboratory Medicine, Lund University Cancer Centre, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0002-6992-3415
Yueyun PanDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Kristian PietrasDivision of Translational Cancer Research, Department of Laboratory Medicine, Lund University Cancer Centre, Lund University, Lund, Sweden.
Mikael C I KarlssonDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. Mikael.Karlsson@ki.se.ORCID http://orcid.org/0000-0001-5582-614X
Karolinska Institutet · SELund University · SE

Funding

Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancerR01CA258324 · NCI · ROCKEFELLER UNIVERSITY · PI KARLSSON, MIKAEL, RAVETCH, JEFFREY VICTOR · 2021 to 2025
$2.7M
NCI NIH HHS R01 CA258324Swedish Cancer Foundation 207-00215Vetenskapsrådet (Swedish Research Council) 521-2013-2395
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cancer-Associated FibroblastsNatural Killer T-CellsNeoplasmsAnimalsAntigens, CD1dHumansMiceStress, PhysiologicalAntigens, CD1d

Identifiers

PMID37735500
PMCPMC10757709
OpenAlexW4386934489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.